MedTrace Logo

Timing of Corticosteroids in COVID-19, II. Post COVID-19 Follow-up

NCT04530409 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 752

Last updated 2023-09-06

No results posted yet for this study

Summary

Timing of of corticosteroids administration is very important in COVID19 cases for the recovery and decrease the mortality.

Conditions

  • Covid19
  • Corticosteroids

Interventions

DRUG

Early-Corticosteroids

early use of dexamethasone/Methylprednisolone as early as laboratory evidence of high inflammatory markers

Sponsors & Collaborators

  • ClinAmygate

    lead OTHER

Principal Investigators

  • Emad R Issak · Assalam Clinics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-20
Primary Completion
2021-11-01
Completion
2023-10-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04530409 on ClinicalTrials.gov